Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1714/3592.35745 http://scihub22266oqcxt.onion/10.1714/3592.35745 33960979!ä!33960979 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       G+Ital+Cardiol+(Rome) 2021 ; 22 (5): 363-375 Nephropedia Template TP {{tp|p=33960979|t=2021. Position paper della Societa Italiana di Cardiologia (SIC): Priorita del vaccino COVID-19 nei pazienti con patologie cardiovascolari |pdf=|usr=}}{{33960979}} gab.com Text Position paper della Societa Italiana di Cardiologia (SIC): Priorita del vaccino COVID-19 nei pazienti con patologie cardiovascolari JO: G Ital Cardiol (Rome) http://www.kidney.de/pget.php?&tw=1&pmid=33960979 #FOAvip In over a year, the COVID-19 pandemic caused 2.69 million deaths and 122 million infections. Social isolation and distancing measures have been the only prevention available for months. Scientific research has done a great deal of work, developing in a few months safe and effective vaccines against COVID-19. In the European Union, nowadays, four vaccines have been authorized for use: Pfizer-BioNTech, Moderna, ChAdOx1 (AstraZeneca/Oxford), Janssen (Johnson & Johnson), and three others are currently under rolling review.Vaccine allocation policy is crucial to optimize the advantage of treatment preferring people with the highest risk of contagion. These days the priority in the vaccination program is of particular importance since it has become clear that the number of vaccines is not sufficient for the entire Italian population in the short term. Cardiovascular diseases are frequently associated with severe COVID-19 infections, leading to the worst prognosis. The elderly population suffering from cardiovascular diseases is, therefore, to be considered a particularly vulnerable population. However, age cannot be considered the only discriminating factor because in the young-adult population suffering from severe forms of heart disease, the prognosis, if affected by COVID-19, is particularly ominous and these patients should have priority access to the vaccination program. The aim of this position paper is to establish a consensus on a priority in the vaccination of COVID-19 among subjects suffering from different cardiovascular diseases. Twit Text FOAVip Position paper della Societa Italiana di Cardiologia (SIC): Priorita del vaccino COVID-19 nei pazienti con patologie cardiovascolari ????G Ital Cardiol (Rome) http://www.kidney.de/pget.php?&tw=1&pmid=33960979 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33960979 #FOAvip English Wikipedia <ref>{{Cite pmid|33960979}}</ref> Position paper della Societa Italiana di Cardiologia (SIC): Priorita del vaccino COVID-19 nei pazienti con patologie cardiovascolari #MMPMID33960979 Indolfi C; Barilla F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Romeo F; Sinagra G; Filardi PP G Ital Cardiol (Rome) 2021[May]; 22 (5): 363-375 PMID33960979show ga In over a year, the COVID-19 pandemic caused 2.69 million deaths and 122 million infections. Social isolation and distancing measures have been the only prevention available for months. Scientific research has done a great deal of work, developing in a few months safe and effective vaccines against COVID-19. In the European Union, nowadays, four vaccines have been authorized for use: Pfizer-BioNTech, Moderna, ChAdOx1 (AstraZeneca/Oxford), Janssen (Johnson & Johnson), and three others are currently under rolling review.Vaccine allocation policy is crucial to optimize the advantage of treatment preferring people with the highest risk of contagion. These days the priority in the vaccination program is of particular importance since it has become clear that the number of vaccines is not sufficient for the entire Italian population in the short term. Cardiovascular diseases are frequently associated with severe COVID-19 infections, leading to the worst prognosis. The elderly population suffering from cardiovascular diseases is, therefore, to be considered a particularly vulnerable population. However, age cannot be considered the only discriminating factor because in the young-adult population suffering from severe forms of heart disease, the prognosis, if affected by COVID-19, is particularly ominous and these patients should have priority access to the vaccination program. The aim of this position paper is to establish a consensus on a priority in the vaccination of COVID-19 among subjects suffering from different cardiovascular diseases. |*Consensus[MESH] |Age Factors[MESH] |Animals[MESH] |COVID-19 Vaccines/*administration & dosage[MESH] |COVID-19/epidemiology/mortality/*prevention & control[MESH] |Cardiology[MESH] |Cardiovascular Diseases/*complications[MESH] |Coronary Disease/complications[MESH] |Disease Vectors[MESH] |Heart Failure/complications[MESH] |Heart Transplantation[MESH] |Heart Valve Diseases/complications[MESH] |Humans[MESH] |Hypertension, Pulmonary/complications[MESH] |Italy/epidemiology[MESH] |Prognosis[MESH] |Renal Insufficiency/complications[MESH] |SARS-CoV-2/immunology[MESH] |Societies, Medical[MESH] |Vaccines, Synthetic/administration & dosage[MESH]Position paper della Societa Italiana di Cardiologia (SIC): Priorita d(epmc).pdf DeepDyve Pubget Overpricing